Molecular Health (MH) is an internationally operating biotech IT company located in Heidelberg, Germany, which has been developing innovative software in the fields of in silico and precision medicine since 2004. The solutions by MH enable large quantities of data to be transformed into evidence-based, medically relevant decision-making tools. They are used where patient care with precision medicine or efficient drug development require increasingly complex interpretation of data. MH specialists from the fields of medicine, data science, biology and bioinformatics as well as software development are working on transforming big data into a useful tool for healthcare. The result is intuitive analysis applications which are individually tailored to various requirements in healthcare. MH is an investment management company of dievini Hopp Biotech holding GmbH & Co. KG.
Additional information can be found at www.molecularhealth.com
#MolecularHealth